What are the causes of elevated beta-hydroxybutyrate (BHB) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated Beta-Hydroxybutyrate

Elevated beta-hydroxybutyrate (BHB) is most commonly caused by diabetic ketoacidosis (DKA) in patients with diabetes, but also occurs in alcoholic ketoacidosis, starvation/fasting states, ketogenic diets, and SGLT2 inhibitor use.

Pathological Causes (Most Clinically Significant)

Diabetic Ketoacidosis (DKA)

  • BHB levels ≥1.5 mmol/L accompanied by hyperglycemia and acidosis are diagnostic of DKA, representing the most critical cause requiring immediate intervention 1
  • Type 1 diabetes with absolute insulin deficiency is the classic setting, particularly in new-onset diabetes, insulin omission, or during infection 2
  • Type 2 diabetes during severe illness or stress can precipitate DKA when insulin secretory capacity becomes overwhelmed 2
  • BHB levels in DKA typically reach 7-8 mmol/L or higher, reflecting profound metabolic derangement 2

Alcoholic Ketoacidosis (AKA)

  • AKA produces high BHB levels (median 500 mg/L or approximately 4.8 mmol/L) with acetone levels around 110 mg/L 3
  • This occurs in chronic alcohol users during periods of poor nutritional intake and relative starvation 3

SGLT2 Inhibitor-Associated Ketoacidosis

  • Patients using SGLT2 inhibitors (like sotagliflozin) can develop "euglycemic DKA" with elevated BHB even when blood glucose is normal or only mildly elevated 1
  • Each 0.1 mmol/L increase in baseline BHB increases DKA risk by 18%, and each 0.1 mmol/L increase from baseline raises risk by 8% 4
  • Baseline BHB levels and changes in BHB are independent predictors of DKA risk regardless of treatment 4

Physiological/Metabolic Causes

Starvation and Fasting States

  • Prolonged fasting or starvation triggers lipolysis and ketone production as the body shifts to fat metabolism for energy 5
  • Overnight fasting typically produces BHB levels around 0.20 mmol/L, which remain in the normal range (<0.6 mmol/L) 6

Ketogenic Diet

  • Intentional carbohydrate restriction induces nutritional ketosis with BHB elevation 5
  • This represents a controlled metabolic state distinct from pathological ketoacidosis 5

Hypothermia

  • Hypothermia as a cause of death is associated with BHB levels around 520 mg/L (approximately 5.0 mmol/L), similar to alcoholic ketoacidosis 3

Clinical Interpretation Framework

BHB Level Thresholds

  • <0.6 mmol/L: Normal range 1
  • 0.6-1.5 mmol/L: Mild to moderate ketosis requiring monitoring 1
  • ≥1.5 mmol/L: Significant ketosis with high DKA risk when accompanied by hyperglycemia and acidosis 1, 2
  • >7-8 mmol/L: Severe pathological ketoacidosis requiring immediate medical attention 2

Critical Diagnostic Pitfall

  • Standard urine dipsticks only detect acetoacetate and completely miss BHB, significantly underestimating total ketone burden 2
  • Blood ketone testing directly measuring BHB is strongly preferred for diagnosing and monitoring DKA 2
  • The nitroprusside reaction should not be used to monitor DKA treatment as it doesn't quantify BHB specifically 1

When to Measure BHB

High-Risk Scenarios Requiring Testing

  • Blood glucose persistently elevated >250 mg/dL in diabetic patients 1
  • During any illness in patients with type 1 diabetes 1
  • When symptoms of ketosis appear (nausea, vomiting, abdominal pain, fruity breath) 1
  • Before intense physical activity in type 1 diabetes patients (postpone exercise if BHB ≥1.5 mmol/L) 1
  • In any patient on SGLT2 inhibitors presenting with metabolic symptoms, regardless of glucose level 1

Special Monitoring Populations

  • Patients with type 1 diabetes should have BHB testing capability at home 1
  • SGLT2 inhibitor users require education on BHB monitoring and DKA risk factors 4
  • Caution is warranted even with BHB ≥0.6 mmol/L in diabetic patients as this may indicate early ketosis 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.